Abstract:What We Already Know about This Topic Opioid-induced respiratory depression results in part from direct activation of &mgr;-opioid receptors expressed in the inspiratory rhythm generator located in the ventrolateral medulla, the preBötzinger Complex Respiratory neurons within the medulla also express nicotinic acetylcholine receptors, which are made up of five subunits, arranged symmetrically around a central pore Activation of the nicotinic acetylcholine receptor &agr;4, &agr;7, and &bgr;2 subunits increases respiratory rhythm, whereas activation of the nicotinic acetylcholine receptor &agr;4&bgr;2 or &agr;7 subunits induces analgesia in multiple forms of pain What This Article Tells Us That Is New The nonselective nicotinic acetylcholine receptor agonist nicotine and the &agr;4&bgr;2 nicotinic acetylcholine receptor agonist A85380, but not the &agr;7 nicotinic acetylcholine receptor agonist PNU282987, reversed respiratory depression induced by activation of &mgr;-opioid receptors in rats both in vitro and in vivo Coadministration of A85380 with fentanyl not only markedly reduced respiratory depression and apneas but also enhanced the fentanyl-induced analgesia Background: Opioid analgesics are widely used for treatment of acute, postoperative, and chronic pain. However, activation of opioid receptors can result in severe respiratory depression. There is an unmet clinical need to develop a pharmacologic therapy to counter opioid-induced respiratory depression without interfering with analgesia. Further, additional advances to confront accidental lethal overdose with the use of fentanyl and other opioids are needed. Here, the authors test the hypothesis that activation of nicotinic receptors expressed within respiratory rhythm–generating networks would counter opioid-induced respiratory depression without compromising analgesia. Methods: Respiratory neural discharge was measured using in vitro brainstem–spinal cord and medullary slice rat preparations. In vivo, plethysmographic recording, nociception testing, and righting reflexes were used to examine respiratory ventilation, analgesia, and sedation, respectively. Results: The administration of nicotine, selective &agr;4&bgr;2 nicotinic receptor agonist A85380, but not &agr;7 nicotinic receptor agonist PNU282987, reversed opioid-induced respiratory depression in neonatal pups in vitro and in vivo. In adult rats in vivo, administration of A85380 (0.03 mg/kg), but not PNU282987, provides a rapid and robust reversal of fentanyl-induced decrease in respiratory rate (93.4 ± 33.7% of control 3 min after A85380 vs. 31 ± 20.5% of control after vehicle, n = 8 each, P < 0.001), without marked side effects. The coadministration of A85380 (0.06 mg/kg) with fentanyl or remifentanil markedly reduced respiratory depression and apneas, and enhanced the fentanyl-induced analgesia, as evidenced by increased paw withdrawal latency in Hargreaves plantar test (14.4 ± 2.8 s vs. vehicle: 11.3 ± 2.4 s, n = 8 each, P = 0.013) and decreased formalin-induced nocifensive duration (2.5 ± 2.4 min vs. vehicle: 5.4 ± 2.7 min, n = 8 each, P = 0.029). Conclusions: The novel strategy of targeting &agr;4&bgr;2 nicotinic acetylcholine receptors has the potential for advancing pain control and reducing opioid-induced respiratory depression and overdose.

Glial TLR4 Signaling Does Not Contribute to Opioid-Induced Depression of Respiration.

G-protein-gated Inwardly Rectifying Potassium Channels Modulate Respiratory Depression by Opioids.

Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelae.

Possible Involvement of Toll-Like Receptor 4/myeloid Differentiation Factor-2 Activity of Opioid Inactive Isomers Causes Spinal Proinflammation and Related Behavioral Consequences

Nucleus Tractus Solitarius Neurons Activated by Hypercapnia and Hypoxia Lack Mu Opioid Receptor Expression

The Role of TNF Α in the Periaqueductal Gray During Naloxone-Precipitated Morphine Withdrawal in Rats

Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement.

Activating &agr;4&bgr;2 Nicotinic Acetylcholine Receptors Alleviates Fentanyl-induced Respiratory Depression in Rats

Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility

PreBotzinger complex neurokinin-1 receptor-expressing neurons mediate opioid-induced respiratory depression

Activating α4β2 Nicotinic Acetylcholine Receptors Alleviates Fentanyl-induced Respiratory Depression in Rats.

Toll-Like Receptor 9 Is Required For Opioid-Induced Microglia Apoptosis

Microglial knockdown does not affect acute withdrawal but delays analgesic tolerance from oxycodone in male and female C57BL/6J mice

Opioids Alleviate Oxidative Stress via the Nrf2/HO-1 Pathway in LPS-Stimulated Microglia

Anatomical distribution of μ-opioid receptors, neurokinin-1 receptors, and vesicular glutamate transporter 2 in the mouse brainstem respiratory network

Inhibitory Effects of Mas-Related Gene C Receptor on Chronic Morphine-Induced Spinal Glial Activation in Rats

Peripheral opioid receptor antagonism alleviates fentanyl-induced cardiorespiratory depression and is devoid of aversive effects

Modeling Insights into Potential Mechanisms of Opioid-Induced Respiratory Depression within Medullary and Pontine Networks

Morphine induces inflammatory responses via both TLR4 and cGAS-STING signaling pathways

Opioid receptor mechanisms at the hypoglossal motor pool and effects on tongue muscle activity in vivo

Countering Opioid-induced Respiratory Depression in Male Rats with Nicotinic Acetylcholine Receptor Partial Agonists Varenicline and ABT 594.